BioPharma Dive - Latest News

Incyte replaces CEO Hoppenot with dealmaker Meury

Bill Meury, who shepherded Karuna and Anthos to multibillion-dollar buyouts, will take over Incyte, a successful drug developer now at a crossroads.

Jun 26, 2025 - 17:45
 0
Incyte replaces CEO Hoppenot with dealmaker Meury

Bill Meury, who shepherded Karuna and Anthos to multibillion-dollar buyouts, will take over Incyte, a successful drug developer now at a crossroads.

Read More

Tags:

Previous Article

Acadia’s ‘very bullish’ sales forecast restores some confidence on Wall Street

Next Article

Recast CDC panel recommends new RSV antibody for infants

Related Posts

Draig, a brain drug startup, debuts with $140M to treat depression

Draig, a brain drug startup, debuts with $140M to treat...

Jun 18, 2025  0

SpliceBio lands $135M for a new kind of eye gene therapy

SpliceBio lands $135M for a new kind of eye gene therapy

Jun 11, 2025  0

Vera drug scores in closely watched study in rare kidney disease

Vera drug scores in closely watched study in rare kidne...

Jun 2, 2025  0